Antigen-driven focal inflammatory death of malaria liver stages by Ganchimeg Bayarsaikhan et al.
MINI REVIEW ARTICLE
published: 04 February 2015
doi: 10.3389/fmicb.2015.00047
Antigen-driven focal inflammatory death of malaria
liver stages
Ganchimeg Bayarsaikhan1,2, Masoud Akbari2, Katsuyuki Yui2 and Rogerio Amino1*
1 Unité de Biologie et Génétique du Paludisme, Département Parasites et Insectes Vecteurs, Institut Pasteur, Paris, France
2 Division of Immunology, Department of Molecular Microbiology and Immunology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
Edited by:
Ute Frevert, New York University
School of Medicine, USA
Reviewed by:
Ute Frevert, New York University
School of Medicine, USA
Ann-Kristin Mueller, University
Hospital Heidelberg, Germany
Volker T. Heussler, University of
Bern, Switzerland
*Correspondence:
Rogerio Amino, Unité de Biologie et
Génétique du Paludisme,
Département Parasites et Insectes
Vecteurs, Institut Pasteur, 28 rue
du Docteur Roux, 75724 Paris
Cedex 15, France
e-mail: roti@pasteur.fr
Multiple immunizations using live irradiated sporozoites, the infectious plasmodial stage
delivered into the host skin during a mosquito bite, can elicit sterile immunity to malaria.
CD8+ T cells seem to play an essential role in this protective immunity, since their
depletion consistently abolishes sterilizing protection in several experimental models. So
far, only a few parasite antigens are known to induce CD8+ T cell-dependent protection,
but none of them can reach the levels of protection afforded by live attenuated parasites.
Systematic attempts to identify novel antigens associated with this efficient cellular
protection were so far unsuccessful. In addition, the precise mechanisms involved in the
recognition and elimination of parasitized hepatocytes in vivo by CD8+ T cells still remain
obscure. Recently, it has been shown that specific effector CD8+ T cells, after recognition
of parasitized hepatocytes, recruit specific and non-specific activated CD8+ T cells to the
site of infection, resulting in the formation of cellular clusters around and in the further
elimination of intracellular parasites. The significance of this finding is discussed in the
perspective of a general mechanism of antigen-dependent focalized inflammation and its
consequences for the elimination of malaria liver stages.
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THE PRE-ERYTHROCYTIC PHASE OF MALARIA INFECTION
Malaria is a mosquito borne disease caused by Plasmodium spp.
parasites. Despite advances in control and prevention measures,
malaria still kills > 600,000 people annually and no effective
licensed vaccine is available so far (www.who.int/malaria/en). The
disease is a consequence of repeated cycles of parasite invasion
and replication inside red blood cells (RBC). However, before
infecting the blood and causing the disease, the parasite must
pass through a silent and asymptomatic pre-erythrocytic (PE)
phase. In mammals, the PE phase starts with the inoculation
of sporozoites into the extravascular regions of the host skin
during a mosquito bite. Some of these highly motile stages get
access to the blood circulation and home to the liver, where they
traverse several hepatic cells before invading and developing, as
liver stages, inside hepatocytes. One infected hepatocyte generates
thousands of RBC-infective stages in 2 to∼10 days depending on
the species. Finally, the PE phase finishes with the release of these
invasive stages into the blood circulation (Ménard et al., 2013).
In contrast to the symptomatic erythrocytic phase of infection,
which can reach the magnitude of ∼1012 circulating infected
RBCs in hyperparasitemic adults (World Health Organization
[WHO], 1990), the asymptomatic PE stages represent the smallest
parasite burden (1∼1000 sporozoites and liver stages) inside the
mammalian host (Medica and Sinnis, 2005). Consequently, these
stages are considered as ideal targets for vaccine intervention,
since early elimination of this minute population of extracellu-
lar sporozoites and intracellular liver stages could strategically
block infection before pathogenesis and transmission of par-
asites to mosquitoes. Most importantly, immunizations using
live sporozoites, which are blocked during hepatic develop-
ment as consequence of irradiation (Nussenzweig et al., 1967),
genetic modification (Mueller et al., 2005) or drugs (Friesen and
Matuschewski, 2011), confer sterile protection against sporozoite
re-infection in several experimental models, as well as in humans
(Seder et al., 2013).
THE PUZZLE OF LIVER STAGE KILLING BY CD8+T CELLS
Although there is evidence that antibodies and CD4+ T cells
contribute to the protection induced by live irradiated sporo-
zoites (Schofield et al., 1987; Tsuji et al., 1990; Rodrigues et al.,
1993; Doolan and Hoffman, 2000), CD8+ T cells seem to be
the major players of this sterilizing immunity since in almost all
tested rodent (Schofield et al., 1987; Doolan and Hoffman, 2000;
Schmidt et al., 2010) and primate (Weiss and Jiang, 2012) models,
sterile protection is abolished when CD8+ T cells are depleted
before sporozoite challenge. Accordingly, the transfer of parasite-
specific CD8+ T cells can also protect mice from sporozoite
infection (Romero et al., 1989; Weiss et al., 1992).
This protective cellular response is associated with a high num-
ber of specific CD8+ T cells circulating in the peripheral blood
of protected mice, ranging from ∼5 to 60% of total circulating
CD8+ T cells (Van Braeckel-Budimir and Harty, 2014). Similarly,
adoptive transfer of ∼107 activated specific CD8+ T cells, which
totalize ∼26 to 60% of CD8+ T cells circulating in the blood, is
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required to sterilize the infection in the liver, while the transfer
of 106 CD8+ T cells, which represents ∼3% of CD8+ T cells
circulating in the blood, is not enough to completely protect mice
against sporozoite challenge (Kimura et al., 2013). In addition,
interactions between CD8+ T cells and infected hepatocytes could
not be observed after adoptive transfer of 106 primed CD8+
T cells to infected mice (Cabrera et al., 2013), suggesting that
the recognition of infected hepatocytes is dependent on high
numbers of specific CD8+ T cells. In humans, however, the levels
of CD8+ T cells correlated with protection seem to be much
lower than in rodents (Ewer et al., 2013). Protective activity is
dependent not only on the quantity, but also on the quality of
CD8+ T cells. For example, high expression levels of cell adhesion
molecules such as CD44 and VLA-4 are correlated with the in
vivo anti-parasite activity of CD8+ T cells, but not with their in
vitro cytotoxic activity (Rodrigues et al., 1992). These molecules
have been implicated in homotypic and heterotypic adhesion of
lymphocytes, in the trafficking of T cells to inflamed site (Nandi
et al., 2004), and could play an important role in the clustering of
T cells at the site of infection (next sections).
Very little is known about the nature of protective parasite
epitopes presented on the surface of infected hepatocytes by
class I major histocompatibility complex molecules (MHC I).
In rodent models, protective MHC I-restricted epitopes were
described in the circumsporozoite protein (CSP, Romero et al.,
1989; Weiss et al., 1992; Rodrigues et al., 1994; Schmidt et al.,
2008) and in the thrombospondin-related anonymous protein
(TRAP, Hafalla et al., 2013). Both CSP and TRAP are membrane
proteins expressed mainly in sporozoites. In humans, immu-
nization using adjuvanted, truncated CSP induced only partial
protection without a detectable specific CD8+ T cell response
(Moorthy and Ballou, 2009). Immunization using TRAP deliv-
ered by viral vectors, which elicit robust T-cell responses, induced
also a partial protection which was correlated with the frequency
of monofunctional interferon gamma (IFNγ)-producing CD8+
T cells (Ewer et al., 2013). Intriguingly, several attempts to iden-
tify new epitopes targeted by CD8+ T cells among thousands
of profiled peptides, mini-genes or genes covering hundreds of
parasite proteins, have revealed only a few new PE candidate
antigens, but none of them induced protection against sporozoite
infection (Mishra et al., 2011; Murphy et al., 2013; Hafalla et al.,
2013). Whether the difficulty to unravel new protective epitopes
is a consequence of the method of screening, which relies on
the secretion of IFNγ by CD8+ T cells detected by ELISPOT, or
of immunization, which may not reach the critical CD8+ T cell
threshold necessary for protection, remains to be determined.
Given the scarcity of protective CD8 epitopes, another con-
venient way to study CD8+ T cell responses against infected
hepatocytes is to use the epitope of ovalbumin (OVA) fused to
endogenous and exogenous antigens expressed in malaria PE
stages (Cockburn et al., 2011; Kimura et al., 2013; Montagna
et al., 2014). This strategy showed that membrane, cytoplas-
mic and tubulovesicular network exported proteins can harbor
epitopes that are presented on the surface of infected hepato-
cytes, leading to the parasite elimination by MHC I–restricted
(H-2Kb), OVA-specific CD8+ T cells (OT-I cells). Although
antigen-presentation is dependent on the transporter associated
with antigen processing (TAP; Cockburn et al., 2011; Kimura
et al., 2013), which translocates peptides from the cytosol into
the endoplasmic reticulum where they are loaded onto MHC I
molecules, the mechanism by which these membrane, cytoplas-
mic and exported parasite antigens cross the parasitophorous
vacuole membrane and reach the host cell cytoplasm is still
controversial and unclear (Singh et al., 2007; Cockburn et al.,
2011; Montagna et al., 2014).
The mechanisms by which CD8+ T cells eliminate liver stages
are also puzzling. Systemic depletion of IFNγ consistently abol-
ishes the sterile protection induced by irradiated sporozoites in
rodent models (Schofield et al., 1987; Doolan and Hoffman,
2000). However, activated IFNγ−/− CD8+ T cells harboring
transgenic T-cell receptors (TCRs), which can recognize specific
cognate epitopes presented on the surface of infected hepatocytes,
are still capable of controlling infection as their IFNγ-proficient
counterparts (Chakravarty et al., 2008; Kimura et al., 2013). The
same is observed for FasL and/or perforin knockout CD8+ T cells
(Morrot and Zavala, 2004; Kimura et al., 2013). Finally, sterile
protection is only lost in a proportion of animals injected with
double IFNγ and perforin knockout CD8+ T cells (Kimura et al.,
2013). Altogether these loss-of-function studies depict a scenario
where the elimination of liver stages by specific CD8+ T cells
seems to be a complex process involving several and redundant
effector molecules and probably other IFNγ-producing immune
cells.
CD8+ T CELL–DEPENDENT INFLAMMATORY FOCI AND THE
DEATH OF LIVER STAGES
While molecular mechanisms underlying the elimination of liver
stages by CD8+ T cells are still unclear, the cellular events leading
to the death of these hepatic parasites are only slowly being
revealed. In 1989, multiple inflammatory foci containing numer-
ous CD11b+, CD8+, and at lesser extent CD4+ cells were first
observed in the liver of BALB/c mice immunized with P. berghei
(Pb) irradiated sporozoites, 43 h after challenge with normal
sporozoites. Although no parasites could be observed in associa-
tion with these infiltrates, the formation of these cellular foci was
dependent on the presence of CD8+ T cells (Hoffman et al., 1989).
Several years later, DNA in situ hybridization revealed rem-
nants of Pb parasites in close association with cellular infiltrates
in the liver of rats immunized with irradiated sporozoites and
challenged with normal sporozoites (Scheller et al., 1997). The
number of infiltrates increased after 24 h post-challenge and
coincided with the decrease in the number of liver stages in the
immunized rats. CD4+ and CD8+ T cells were also identified
in these infiltrates. The number of CD4+ cells was maintained
constant at 31 h and 44 h post-infection, while the number of
CD8+ T cells was four and sixfold superior to those of CD4+ T
cells at these respective time points.
Notably, systemic inhibition of nitric oxide (NO) production
by aminoguanidine reduced the number of inflammatory foci
after 24 h post-infection with a clear diminution of the number
of CD8+ lymphocytes in the focal infiltrates (Scheller et al.,
1997). This treatment also abolished the elimination of liver
stages in the immunized animals indicating that the production
of NO is critical for the accumulation of CD8+ T cells, which
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are necessary for the parasite elimination. However, the source of
inducible NO synthase in the liver of immunized rats challenged
with sporozoites seems to be restricted to infected hepatocytes
(Klotz et al., 1995). Since NO produced by infected hepatocytes
is involved in the elimination of parasites in vitro in the absence
of T cells (Nussler et al., 1993; Mellouk et al., 1994), it is not
possible to distinguish if aminoguanidine abolished elimination
of liver stages in the immunized animal by the direct inhibition
of NO anti-plasmodial activity, by the inhibition of inflammatory
responses that induce the accumulation of CD8+ T cells around
the infected hepatocytes, or both. Studies using specific CD8+
T lymphocytes or liver cells that are deficient in the inducible
synthesis of NO could precise the role of this molecule in the
killing of liver stages.
ANTIGEN-DRIVEN INFLAMMATORY FOCI
Recently, in vivo imaging revealed CD8+ T cell infiltrates in close
association with infected hepatocytes in BALB/c mice immunized
with irradiated P. yoelii (Py) sporozoites (Cockburn et al., 2013).
The use of fluorescent CD8+ T cells harboring transgenic TCRs,
specific for epitopes expressed by the parasite and presented by
MHC I molecules on the surface of infected hepatocytes, also
showed that cluster formation mediated by CD8+ T cells is anti-
gen specific. Activated CD8+ T cells, which recognize specifically
a PyCSP-epitope, clustered around and eliminated Py infected
hepatocytes. Conversely activated OT-I cells did not cluster or
eliminate Py and Pb infected hepatocytes, but readily clustered
around and eliminated hepatocytes infected with Pb expressing
the CD8 epitope of OVA (Cockburn et al., 2013; Kimura et al.,
2013). The frequency distribution of PyCSP-specific CD8+ T cells
around infected hepatocytes fitted a mathematical model where
the recruitment of T cells was density-dependent, indicating that
activated CD8+ T cells were attracted to a cluster. The close
apposition of CD8+ T cells with infected hepatocytes suggests
that this first step of specific recognition and recruitment is
initiated by the direct contact between these two cells (Figure 1A).
Hepatocytes traversed by sporozoites are also thought to present
antigens to CD8+ T cells. Although traversed hepatocytes do not
alter the elimination of infected cells by CD8+ T cells in vitro
(Bongfen et al., 2007), the role of liver cells traversed by sporo-
zoites (Mota et al., 2001; Tavares et al., 2013a,b) located adjacent
to infected hepatocytes cannot be formally excluded in the process
of initiation and formation of these cellular inflammatory foci
(Figure 1B). This capacity of CD8+ T cells to recognize a cognate
antigen and recruit other CD8+ T cells to the site of infection
seems to be a general and novel function of CD8+ T cells, as
reported recently in a model of mouse reproductive tract infection
by the lymphocytic choriomeningitis virus (Schenkel et al., 2013).
Surprisingly, when activated PyCSP-specific and non-specific
CD8+ T cells were transferred together in mice infected with Py
sporozoites, non-specific CD8+ T cells, which usually did not
cluster around Py infected hepatocytes, modified their behavior
and were recruited together with PyCSP-specific CD8+ T cells
to the site of infection (Cockburn et al., 2013). In a tumor
model, activated OT-I cells were also responsible for the deep
infiltration and accumulation of activated non-specific T cells in
OVA-expressing EL4 tumors (Boissonnas et al., 2007), indicating
FIGURE 1 | Model of the elimination of malaria liver stage by a CD8+
T cell-dependent inflammatory cell cluster. (A) Parasite antigens cross the
parasitophorous vacuole membrane (PVM), are processed and presented on
the surface of the infected hepatocyte by MHC I molecules, and/or (B) are
released in the cytoplasm and presented on the surface of hepatic cells
(hepatocytes, Kupffer cells, endothelial cells—figuratively represented by the
pink cells) traversed by sporozoites. (A,B) Parasite-specific, activated CD8+
T cell (red cell) recognizes its cognate antigen and (C) recruits other specific
and non-specific (purple cells) CD8+ T cells, and presumably other
leukocytes (orange cells) to the site of infection. (D) These immune cells
cluster around the infected hepatocyte, leading to the elimination of the
malaria liver stage and presumably of the infected hepatocyte. For clarity and
due to the lack of information about its position during cluster formation, the
sinusoidal barrier is not represented in the model.
that CD8+ T cells not only exert a direct cytotoxic activity on
target cells, but can also orchestrate a focal inflammatory response
by the recognition of a specific antigen and further recruitment of
specific and non-specific T cells to the site of infection or tumor
growth. This inflammatory role is in agreement with the recent
observation that CD8+ T cells express a burst of inflammatory
cytokines immediately after cognate antigen stimulation recruit-
ing diverse cellular types involved in inflammatory reactions
(Sung et al., 2013).
MULTIPLICITY OF PARASITE DEATH PHENOTYPES
Dynamic imaging revealed how clusters of activated CD8+ T cells
eliminate liver stages in vivo (Cockburn et al., 2013; Kimura
et al., 2013). The utilization of a vitality index (VI) based on the
fluorescence intensity of GFP-expressing liver stages permitted the
monitoring of parasite viability/death over hours of observation
after the transfer of activated and specific CD8+ T cells. Strikingly,
killing of liver stages was a lasting process, which on average
occurred after several hours of association between CD8+ T cells
and infected hepatocytes. In addition, the kinetics of the VI of
fluorescent parasites allowed the discrimination of at least three
distinct death phenotypes (DPs) associated with the presence of
activated CD8+ T cells. An abrupt decrease in the parasite VI
followed by the diffusion of a weak GFP signal through the host
cell cytoplasm characterized the first DP. The second DP was
characterized by a slow decrease in the VI over hours of inter-
action. The blebbing of the infected hepatocyte with the release of
parasite material into the sinusoids characterized the third DP. All
these distinct DPs suggest again that parasite elimination could
rely on multiple and redundant mechanisms of killing.
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A better understanding of these killing mechanisms might
be achieved using functional in vivo imaging. This strategy is
a double approach that combines the quantitative imaging of
mutant cells with the imaging of non-mutant cells using spe-
cific fluorescent reporters to investigate function (Tavares et al.,
2013a). For example, the correlation between the ablation of a
cytotoxic effector molecule in protective CD8+ T cells and the
loss of a given DP could indicate a causal relation between these
two variables. Complementary, the use of fluorescent markers that
report the level of expression of cytotoxic molecules (Croxford
and Buch, 2011; Mouchacca et al., 2013) could be used to discrim-
inate different populations of protective CD8+ T cells and their
relationship with the DPs could be assessed by in vivo imaging.
The latter approach could also reveal what is the activation
phenotype of CD8+ T cells associated with efficient homing to
the liver, recognition of infected hepatocytes, clustering formation
and killing of liver stages.
CLUSTERING OF CELLS FACILITATES ELIMINATION OF LIVER
STAGES
Qualitatively a few CD8+ T cells are sufficient to rapidly eliminate
a liver stage in vitro (Trimnell et al., 2009), however, the killing
process in vivo seems to be much longer and complex, involving
multiple cells (Cockburn et al., 2013). Whether these differences
are due to intrinsic characteristics of CD8+ T cells used in
these studies or are a consequence of limitations imposed by
an in vitro system is not yet determined. The liver possesses an
immune-privileged environment, which confers a relatively high
resistance against CD8+ T cell responses (Pircher et al., 2006).
This fact could explain the long time that these cells require to
eliminate liver stages in vivo. Cell clustering triggered by antigen-
specific CD8+ T cells might possibly facilitate the process of
parasite killing by augmenting the local concentration of pro-
tective cellular and molecular effectors. To test this hypothesis,
cluster formation was inhibited by targeting chemokine signaling.
Chemokines act on T cells via G-Protein Coupled Receptors
(GPCRs) signaling. Pertussis toxin (PTx) was used to inhibit
GPCR signaling through the ADP-ribosylation and uncoupling of
G-Proteins (Cotton and Claing, 2009). Activated PyCSP-specific
CD8+ T cells treated with PTx had an impaired capacity to cluster
around and eliminate infected hepatocytes, while maintaining
their capacity to kill target cells and secrete cytokines in vitro,
as well as, to home to the liver in vivo (Cockburn et al., 2013).
Although this pharmacological approach indicates that the clus-
tering of cells triggered by PyCSP-specific CD8+ T cells around
infected hepatocytes facilitates the elimination of malaria liver
stages, the identification of the chemokine(s) involved in the
recruitment of cells to a cluster is still missing. The discovery
of these molecules will permit a precise assessment, e.g., using
knockout animals, of the role of cell clustering in the elimination
of malaria liver stages.
CONCLUDING REMARKS AND PERSPECTIVES
Altogether these data suggest that CD8+ T cell-dependent elim-
ination of liver stages is a complex and cooperative process
involving multiple cells and effector molecules. An elevated num-
ber of CD8+ T cells with a proper binding phenotype seem to
be required for finding and eliminating the scarce population
of infected hepatocytes in the liver. Following antigen-specific
recognition of the site of infection by activated CD8+ T cells,
both specific and non-specific CD8+ T cells and likely other
immune cells are recruited to the site of infection. Finally infected
hepatocytes are cleared by these antigen-driven inflammatory
foci, displaying a multiplicity of DPs. This mechanism of killing
places CD8+ T cells as an essential linker between a specific
adaptive immune response, which starts with the recognition of
an infected cell, and a non-specific immune response, charac-
terized by the recruitment of inflammatory cells to the site of
infection and ensuing elimination of liver stages (Figure 1). This
multi-cellular cooperative model of killing can also incorporate
the relative importance of other cellular types, like CD4+ T
cells and other IFNγ-producing cells, in the foci composition
and protection. It may also explain the general dependence
on IFNγ for sterile immunity but the dispensable role of this
cytokine for protection induced by parasite-specific IFNγ−/−
CD8+ T cells.
Important topics related to the formation, composition and
killing efficacy of these CD8+ T cell-dependent inflammatory
foci are still unclear and need further investigation. One of
these topics is the identification of novel protective CD8 epitopes
presented on the surface of hepatocytes (Crabb et al., 2012) and
the verification of their concerted action with other known pro-
tective epitopes, such as those described in CSP and TRAP. This
approach could reveal a possible synergistic, additive, neutral or
antagonistic effect on cluster formation and protection. Another
important subject to address is the contribution of CD8+ T
cells, which cannot recognize infected hepatocytes, but are specif-
ically activated in the lymph node that drains the bite site, for
example, by mosquito saliva or sporozoite antigens (Chakravarty
et al., 2007), in foci formation and elimination of liver stages.
Once it is determined that the recruitment of these activated
CD8+ T cells to infected hepatocytes can improve the killing
of liver stages, a vaccination strategy using protective epitopes,
presented by infected hepatocytes, and inflammatory epitopes,
which might improve killing by focal inflammation, could be
envisaged and tested. Similarly the role of non-specific innate
immune cells in cluster formation and killing activity is also an
open question. It is well documented that inflammatory infiltrates
are associated with the natural resistance of naïve rodents to
hepatic infection (Khan and Vanderberg, 1991), but their role in
immunized animals is not known. In addition, depletion stud-
ies using multiple doses of anti-asialo GM1 antibodies partially
abrogated protection induced by irradiated sporozoites in several
mouse strains (Doolan and Hoffman, 2000). This treatment is
known to efficiently deplete NK cells and basophils, and despite
the expression of asialo GM1 on subpopulations of NKT, CD8+
T and γδ T cells, no significant depletion was observed after
a single dose of anti-asialo GM1 antibodies in C57BL/6 mice
(Nishikado et al., 2011). This suggests that NK cells, basophils
and other innate immune cells could also participate in the
focal inflammation orchestrated by specific CD8+ T cells. Finally
the unraveling of the molecular determinants of highly protec-
tive CD8+ T cells is crucial for defining the type of effector
cells a vaccine should generate. All this information could be
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very useful for the design of an immunization strategy aiming
at the efficient elimination of malaria liver stages mediated by
CD8+ T cells.
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